When Dr. Jennifer Ritonja joined BC Cancer in July 2025 as a scientist, she set out to advance how we detect and prevent cancer in women. A trained epidemiologist, her research focuses on identifying early indicators of cancer in women, particularly for breast and ovarian cancers.
We’re pleased to welcome Dr. Jennifer Ritonja to the Population Health Sciences department. Jen joins us as a scientist, bringing valuable expertise in cancer epidemiology.
We were pleased to host a well-attended Special Talk on Thursday, July 24 as part of our Summer Student Get-together Series. The session brought together students, trainees, recent graduates, and department members interested in exploring career paths.
The talk "Critical Career Readiness Skills," explored how today’s evolving job landscape calls for adaptable and transferable skills.
A pan-Canadian research team led by Dr. Helen McTaggart-Cowan, a BC Cancer scientist, will receive $183,500 through a new Patient Voices in Research Initiative from the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network (the Network) to examine barriers to accessing homologous recombination deficiency (HRD) testing for patients with advanced ovarian cancer.
Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!
This year’s awardees are:
In a new study, a team led by Dr. Dean Regier, Senior Scientist in Cancer Control at BC Cancer and co-chair of the MOHCCN Health Technology Assessment Working Group, conducted focus groups with individuals with lived and living experience with cancer to understand their values, expectations, and concerns for enhanced data sharing.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.